New hope for Huntington's chorea: valbenazine safety trial expands
Symptom relief
ENROLLING_BY_INVITATION
This study looks at the long-term safety of valbenazine for treating chorea (involuntary movements) in people with Huntington disease. It is for 7 participants in Canada who were in a previous valbenazine study. The main goal is to track any side effects over time.
Phase: PHASE3 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC